Life Technologies to Provide Ion Torrent Sequencing Platform to Quest Diagnostic

Life Technologies LIFE has completed a multi-year license and supply agreement with Quest Diagnostics DGX that gives Quest rights to develop molecular tests on the Ion Torrent™ next-generation sequencing platform. Under the agreement, Quest may use the platform and related consumables to independently develop new tests for numerous areas of their business.  See full press release